This Insmed Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
Alpha Vantage · Benzinga · · AI-summarised by FinFlash
Five notable analyst downgrades were issued, hitting UWM Holdings, Enact Holdings, Roivant Sciences, Insmed and Monday.Com. Analysts at BTIG, JP Morgan, Wolfe Research and Barclays revised ratings, with some also cutting price targets. Wolfe Research downgraded Insmed from Outperform to Peer Perform, the move highlighted in the headline.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.